Noom HRT Review (2026): What the $89 and $149 Plans Actually Contain

Disclosure: The HRT Index is not affiliated with Noom and receives no compensation from Noom links on this page. We may earn a commission from clearly labeled links to other providers. (full affiliate disclosure)

This Noom HRT review finds a real clinician-led cash-pay program with one damaging split: the $89 monthly cream route is compounded and not FDA-approved, while the $149 monthly route uses an FDA-approved estradiol patch. It fits women who want systemic HRT plus Noom’s behavior program, not insurance-first or vaginal-symptom care.

Best for: women paying cash who want systemic menopause treatment bundled with food tracking, coaching, movement support, and Noom’s habit program.

Not for you if: your main problem is vaginal dryness, painful sex, or urinary symptoms; you want insurance-billed care; you want a wider published medication menu; or you do not want menopause care wrapped in a weight-management platform.

	Compounded estrogen body cream route	FDA-approved estradiol patch route
Published price	$69 to start, then $89/month	$99 to start, then $149/month
Estrogen product	Compounded bi-est body cream containing estradiol and estriol	FDA-approved estradiol patch
FDA-approved finished medication?	No	Yes
Published strength	Not published	Not published
Progesterone price inclusion	Not separately stated	Not separately stated
Insurance billed by the direct retail program	No	No
Public state-by-state availability list	Not found	Not found
Published clinician-message target	Usually within 36 hours	Usually within 36 hours

Provider-stated prices and program details checked August 17, 2026. Noom does not define how long either “to start” price lasts, so this page does not present those figures as confirmed first-month prices.

Noom’s own pages confirm the regulatory split, but not where the price is displayed. The current Noom cost page puts the $89 and $149 routes side by side; the separate HRT safety page is where Noom identifies the cream as compounded and the patch as FDA-approved. A woman choosing on price can therefore reach the cheaper route without seeing the FDA distinction at the price point.

That is the central finding. It is not a claim that compounded medication is illegal, fake, or always wrong. It is a claim that the regulatory category changes with the price, and that difference belongs beside the price before a woman pays.

Is Noom’s HRT program right for you? It depends on things a review cannot see.

No review can decide whether systemic estrogen, local vaginal treatment, a nonhormonal option, or in-person evaluation is the right starting point for your body. Noom can be a clean fit when its narrow formulary matches your symptoms; it becomes the wrong door quickly when it does not.

The right online HRT provider isn't the same for every woman — it depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state. Some situations belong with an in-person clinician first. Because a general answer can't resolve those for you, use The HRT Index's Find My HRT Path tool to match your situation to the right provider — and to flag when online care isn't the right starting point — before your first consult.

The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.

What does this Noom HRT review find about the $89 and $149 plans?

The cheaper Noom route uses a compounded estradiol–estriol body cream that the FDA has not approved as a finished drug. The higher-priced route uses an FDA-approved estradiol patch. Noom states both prices publicly, but the price block itself does not identify which route has FDA approval.

Here is the exact decision in front of you:

Question	$89 cream route	$149 patch route
What estrogen do you receive?	Compounded estradiol + estriol body cream	FDA-approved estradiol patch
Did the FDA review the finished estrogen product for safety, effectiveness, and manufacturing quality?	No	Yes
Does the product have standardized FDA-approved prescribing information?	No FDA-approved label for the compounded finished product	Yes
Is estriol present?	Yes	No
Is any estriol-containing drug FDA-approved in the United States?	No	Not applicable
Can Noom’s compounded prescription be filled at any retail pharmacy?	Noom’s terms say some compounded prescriptions are restricted to platform pharmacies	An approved patch prescription can generally be sent to a retail pharmacy, subject to the prescriber, availability, and plan rules
Is the prescribed strength published before intake?	No	No
Is progesterone’s inclusion in the headline price separately confirmed?	No	No

The blunt version: Noom’s cheap door is the compounded door.

The fair version: Noom is not hiding the fact everywhere. Its safety page states that compounded medications are not reviewed by the FDA for safety, quality, or efficacy. The problem is placement. The woman comparing $89 with $149 should not need a second page to discover that the products sit in different regulatory categories.

What is Noom + HRT Rx, exactly?

Noom + HRT Rx is Noom’s direct-to-consumer menopause program, launched February 28, 2025. It combines access to a licensed clinician and prescribed medication, when appropriate, with Noom’s food logging, coaching, movement content, menopause education, and behavior-change tools.

Noom is the platform and subscription brand. Its terms explain that medical services are delivered by licensed healthcare providers through separate medical groups, not by Noom, Inc. itself. That distinction matters: the clinician—not the app, the marketing page, or the person completing the intake—decides whether medication is appropriate and what to prescribe.

According to Noom’s published program pages, the subscription can include:

• a medical intake and clinical evaluation;
• access to an HRT prescription if the clinician determines it is appropriate;
• the prescribed medication for the medication-included route;
• medication tracking and in-app clinical messaging;
• food and activity tracking;
• coaching and check-ins;
• weekly meal planning;
• Muscle Defense™ resistance-training content;
• menopause education and community features.

That bundle is not filler. It is the reason to choose Noom rather than an unbundled telehealth visit or a local prescriber. The woman who will use the app is buying one connected program. The woman who only wants a prescription is paying for a large layer she may never open.

What Noom is not: a broad menopause clinic with a publicly listed patch, gel, spray, pill, vaginal estrogen, nonhormonal, and testosterone menu. Noom’s published HRT formulary is narrow: an FDA-approved transdermal estradiol patch, an FDA-approved oral micronized progesterone pill when clinically indicated, and a compounded estradiol–estriol body cream.

How much does Noom HRT cost?

Noom publishes $69 to start and then $89 per month for the compounded cream route, or $99 to start and then $149 per month for the FDA-approved patch route. Noom says the price covers the prescription, clinical guidance, and its wellness tools, but it does not define the introductory term or separately state whether progesterone changes the price.

Published item	What Noom states	What remains unresolved before checkout
Compounded cream route	$69 to start, then $89/month	Length of intro period; billing term; taxes; exact prescribed strength; progesterone price inclusion
FDA-approved patch route	$99 to start, then $149/month	Length of intro period; billing term; taxes; exact patch product and strength; progesterone price inclusion
Included services	Prescription, clinical guidance, Noom wellness tools	Exact scheduled follow-up cadence; whether a synchronous visit is required for your case
Shipping	Most medication-included Noom Med medications ship in 3–7 business days	Whether your first HRT shipment follows that standard; expedited options; pharmacy identity

The annual math is conditional, not a quote

If—and only if—the “to start” price covers the first month and eleven regular monthly charges follow, the arithmetic would be:

• Cream route: $69 + (11 × $89) = $1,048 before tax.
• Patch route: $99 + (11 × $149) = $1,738 before tax.

Those are useful illustrations, not verified annual prices. Noom has not published what period the introductory payment buys or whether the program bills one month at a time. The final amount can also change if taxes apply or if progesterone is not included in the quoted route.

Noom is much more explicit on several weight-medication products, where it identifies the first supply period and quarterly billing. The HRT pricing copy does not provide the same detail. That makes this the right question to ask before a card goes in:

“What period does the introductory payment cover, what will be charged next, on what date, and is the recurring amount billed monthly or as a longer prepaid term?”

Save the answer. In a subscription product, the billing unit is part of the price.

For the full arithmetic and cancellation scenarios, see the Noom HRT cost breakdown.

You now know the two published prices. The next decision is whether the medication, clinician access, and app layer inside that price are the combination you actually need. Get your personalized starting-point plan with Find My HRT Path →

What does the price include—and what is still unconfirmed?

Noom markets both HRT routes as medication-included subscriptions with clinical guidance and full wellness tools. The unresolved items are not small print: progesterone inclusion, intro-term length, the exact pharmacy, state availability, prescribed strength, and the follow-up cadence can all change what the program means for one woman.

The Noom HRT provider-stated vs. verified ledger

Decision fact	Provider-stated	What we could verify	Status on August 17, 2026
Cream price	$69 to start, then $89/month	Appears on Noom’s current cost page and launch announcement	Verified as published
Patch price	$99 to start, then $149/month	Appears on Noom’s current cost page and launch announcement	Verified as published
Medication included	Noom says the price covers the prescription	Noom’s cost page describes the routes as medication-inclusive	Verified at program level
Progesterone	Noom lists oral micronized progesterone and says a patient without a uterus may not receive it	No separate statement says whether progesterone is included in both headline prices for a patient with a uterus	Confirm before paying
Intro period	“To start”	No public duration or next-charge date found in the HRT price block	Confirm at checkout
Taxes	No HRT-specific tax statement in the price block	Noom’s terms state displayed prices generally exclude taxes unless stated otherwise	May be additional
Shipping	Medication ships to the member	Noom says most medication-included Noom Med medications ship within 3–7 business days	Published general service level
State availability	Eligibility depends on location	No public HRTRx state-by-state list found	Confirm before paying
Refunds	Noom Med refund policy applies	Refunds may be available before a prescription is written; medication-included programs are nonrefundable after a prescription is written; renewal charges are nonrefundable	Verified policy
Cancellation	Cancel through the app, web subscription portal, or app store when applicable	Deleting the app does not cancel; access normally continues to the end of the paid term	Verified policy
Existing Noom subscription	HRT launched as an upgrade	Noom’s current Med upgrade instructions say an existing Noom Weight or Premium subscription ends when the Med upgrade begins	Verified for the published upgrade flow
Clinician messaging	Ongoing access	Noom says replies through “Your Doctor” usually arrive within 36 hours	Verified service target
Labs	No routine HRT lab requirement stated	No HRTRx page we found publishes routine bloodwork as a universal requirement	Not published as universally required
Video visit	No mandatory visit format stated	No HRTRx page we found publishes a mandatory video visit for every patient	Not published as universally required

This table is the line between “unknown” and “bad.” An unpublished detail is not automatically a negative. It becomes a negative when it changes cost, access, or treatment fit and the woman cannot see it before paying.

The biggest unresolved item is progesterone. If you have a uterus and receive systemic estrogen, the progestogen decision is a safety decision, not an optional upgrade. Noom publishes oral micronized progesterone as part of its formulary, but does not separately state how that prescription affects the headline cream or patch price.

Ask this first:

“If I have a uterus and your clinician prescribes progesterone with estrogen, is the progesterone included in the quoted monthly price?”

What hormones does Noom actually prescribe?

Noom’s public HRT materials identify three products: an FDA-approved transdermal estradiol patch, an FDA-approved oral micronized progesterone pill, and a compounded transdermal body cream containing estradiol and estriol. Noom publishes no HRT gel, spray, oral estrogen, vaginal estrogen, or testosterone product in this program.

Published product	Route	Regulatory status of finished product	Public strength?	Main unresolved detail
Estradiol patch	Systemic transdermal	FDA-approved	No	Product, dose, change schedule, retail-pharmacy option
Micronized progesterone pill	Oral	FDA-approved	No	Whether included in each headline price and prescribed schedule
Estradiol–estriol body cream	Systemic transdermal compounded cream	Not FDA-approved	No	Estradiol/estriol ratio, dose, pharmacy, beyond-use date

The estradiol patch

The patch delivers systemic estradiol through the skin. FDA-approved estradiol patches come in different strengths and change schedules; Noom does not identify the manufacturer, NDC, strength, or schedule on its public pricing page. That does not make the route illegitimate. It means you should obtain the exact product and dose in writing before the first shipment.

The progesterone pill

Noom says its progesterone pill contains micronized progesterone and is primarily used to balance estrogen’s effects on the uterus. Its safety page states that a patient without a uterus may not receive progesterone, because treatment is individualized.

For a woman with a uterus using systemic estrogen, adequate endometrial protection is not a billing footnote. Estrogen without appropriate progestogen can stimulate the uterine lining and raise endometrial cancer risk. The clinician should decide the formulation, dose, and schedule; the program should make the cost visible.

The compounded bi-est body cream

Noom says the body cream combines estradiol and estriol. It also calls estriol “gentler” and says it is included to reduce side effects. The FDA does not support that safety implication: it says there is no evidence that estriol-containing drugs are safer forms of estrogen, and no estriol-containing drug is FDA-approved in the United States.

The final compounded cream is not FDA-approved even though estradiol also appears in FDA-approved products. The finished formulation, dose, absorption, manufacturing controls, and evidence package are what matter. This page will not use an approved ingredient to imply approval of an unapproved compounded product.

Is Noom HRT FDA approved?

Partly. Noom’s estradiol patch and micronized progesterone pill are described as FDA-approved finished drugs. Noom’s estradiol–estriol body cream is compounded and not FDA-approved. The lower published recurring price belongs to the compounded route; the higher price belongs to the FDA-approved estrogen route.

The Noom HRT regulatory-price ledger

What you are choosing	Published recurring price	FDA status	What the status means
Estradiol–estriol body cream route	$89/month	Compounded; not FDA-approved	The FDA has not reviewed the finished product for safety, effectiveness, or manufacturing quality before marketing
Estradiol patch route	$149/month	FDA-approved	The finished drug has an FDA-reviewed application, standardized labeling, and approved manufacturing controls
Micronized progesterone	Not separately priced by Noom	FDA-approved	The public program page lists it, but headline-price inclusion remains unconfirmed

The same $89/$149 split appears at Winona—but that is not the whole market

Winona currently publishes an estrogen body cream from $89 per month and an FDA-approved estrogen patch from $149 per month. That exact split proves Noom is not the only cash-pay company placing a cheaper compounded route beside a higher-priced FDA-approved patch.

It does not prove that every telehealth provider uses the same convention. Two companies are a pattern worth recognizing, not a universal market law.

The useful takeaway is narrower and stronger:

At both Noom and Winona, choosing by the lower headline price selects the compounded route. Check regulatory status before comparing prices across providers.

What the 2023 estrogen-exposure study can—and cannot—tell you

A 2023 retrospective study in Menopause compared urinary estradiol exposure among women using compounded transdermal estradiol creams and women using FDA-approved estradiol patches or gels. Within the study’s dose groupings, the compounded estradiol creams were associated with lower urinary estradiol exposure than comparable approved patches and gels.

That finding is relevant because it shows that milligram labels and routes cannot simply be treated as interchangeable across compounded creams and approved transdermal products.

It is not a direct test of Noom’s bi-est cream. The study evaluated compounded estradiol creams, while Noom’s public description includes both estradiol and estriol; Noom does not publish its dose; and the study did not establish symptom outcomes for Noom patients. The defensible conclusion is not “Noom’s cream works less.” It is this:

Noom’s unpublished cream strength and formulation prevent a clean dose-for-dose comparison with its patch. Ask for the exact prescription, then judge the route with your clinician rather than assuming the cheaper cream is a lower-cost version of the same product.

What Noom does well on compounded-drug disclosure

Noom publishes three concrete quality-control statements:

1. Partner pharmacies use preparations Noom describes as USP-compliant.
2. Noom says compounded medications undergo internal and third-party testing.
3. Noom says a Certificate of Analysis is available for each medication dispensed.

Those are useful facts. They are not FDA approval.

A Certificate of Analysis can document specifications or test results associated with a preparation or batch. It does not establish that the FDA approved the finished drug, that the product is clinically equivalent to an FDA-approved patch, or that it has proven the same outcomes. Ask for the certificate, the pharmacy name, the prescribed concentration, and the dosing directions together.

“Bioidentical” does not settle the question

“Bioidentical” describes molecular structure. It does not tell you whether a product is FDA-approved or compounded. FDA-approved estradiol products and FDA-approved micronized progesterone are commonly described as bioidentical; custom-compounded products can also contain hormones described that way.

Bioidentical is not a regulatory category. The words you need are “FDA-approved finished drug” or “compounded finished drug.”

Does the FDA-approved route fit what you came looking for? Noom’s current published route is the $149 patch plan. See Noom’s current menopause program and check eligibility → (editorial link; The HRT Index receives no compensation from Noom).

What does “compounded bioidentical HRT” actually mean?

Compounded HRT is prepared by a pharmacy for an individual prescription instead of sold as a finished FDA-approved drug. Compounding can solve a real clinical problem when an approved product cannot meet a patient’s needs, but major U.S. medical and scientific bodies do not treat it as automatically safer, more effective, or preferable to available FDA-approved options.

Authority	Verified position relevant to this decision
FDA	Compounded “bioidentical” hormones are not FDA-approved; the agency has no evidence they are safer or more effective than FDA-approved menopause therapy. No estriol-containing drug is FDA-approved.
The Menopause Society	FDA-approved bioidentical products exist; custom-compounded products are not required to create a bioidentical regimen and have less predictable evidence and oversight.
ACOG	Its 2023 Clinical Consensus says compounded bioidentical menopausal hormone therapy should not be prescribed routinely when FDA-approved formulations exist.
Endocrine Society	It says little or no scientific evidence supports claims that compounded bioidentical HRT is safer or more effective and that FDA-approved bioidentical options are available.
NASEM	Its FDA-commissioned review found limited high-quality evidence for the safety and effectiveness of compounded bioidentical hormone therapy and recommended tighter limits and oversight.

About estriol specifically

Noom’s cream contains estriol. The accurate regulatory facts are simple:

• no estriol-containing drug is FDA-approved in the United States;
• estriol may be used in a compounded prescription under applicable federal and state compounding law;
• lawful compounding is not FDA approval;
• the FDA says it has no evidence that estriol-containing drugs are safer forms of estrogen.

That is enough to make the decision. A longer regulatory timeline adds heat without changing the practical question: the product may be lawfully compounded, but it is not FDA-approved and should not be sold as a safer estrogen.

When a compounded route can make sense

A compounded prescription can be a reasonable answer when a patient has a documented allergy to an ingredient in available approved products, needs a dose or dosage form that is not commercially available, or has another individualized need the prescriber can explain.

The question is not whether compounding can ever be appropriate. It can. The question is whether you have the specific need that makes the compounded route worth choosing over an available FDA-approved product.

Ask the clinician:

“What problem does this compounded formulation solve for me that an FDA-approved estradiol product would not?”

A clear answer earns confidence. “It is more natural” does not.

Is Noom HRT legitimate?

Yes. Noom publicly operates a real menopause program, publishes its prices and formulary, identifies women’s-health clinical leaders, and connects patients with licensed clinicians through medical-provider entities. The trust gaps are not whether Noom exists; they are the missing state list, pharmacy identity, strength details, follow-up schedule, and price treatment of progesterone.

Noom publishes the following clinical leadership for the program:

• Dr. Julia Edelman, MD, Executive Director of Women’s Health. Noom states that she is a gynecologist and Menopause Society Certified Practitioner and lists her education, academic work, books, and professional awards.
• Dr. Karen Mann, MD, Medical Director. Noom states that she is a board-certified OB-GYN, a Menopause Society Certified Practitioner, and a diplomate of the American Board of Obesity Medicine.
• Yalda Olcott, PharmD, Head of Healthcare and Pharmacy Operations, with published experience in pharmacy operations, medication management, and formulary work.

Those are Noom-published credentials. They are more transparent than a faceless “medical team” page, but leadership biographies do not tell you who will review your intake, whether that clinician is licensed in your state, or how often you will receive scheduled follow-up.

What legitimacy does not answer

A legitimate company can still be the wrong provider for a specific symptom. A qualified clinician cannot prescribe a vaginal product the program does not carry. A real cash-pay subscription can still be poor value for someone with strong insurance. A recognized brand can still publish a price without defining the billing term.

That is why this review separates five things in order: clinical legitimacy, care quality, medication fit, price transparency, access. A provider can pass the first pillar and lose you on the fourth or fifth.

What remains unverified

Question	Status
Which states Noom + HRT Rx currently serves	No public state-by-state list found
Which pharmacy will dispense the compounded cream	Noom publicly says “partner pharmacies”; the patient-specific pharmacy is not identified before intake
Whether Noom-owned Tailor Made Compounding fills this cream	Not verified; Noom acquired Tailor Made in April 2026, but no public source ties it to Noom’s HRT cream
Whether progesterone is included in each headline price	Not separately published
Exact estradiol patch product and strength	Not publicly listed
Exact cream concentration and estradiol/estriol ratio	Not publicly listed
Scheduled follow-up cadence	Not publicly listed
Mandatory video visit for every patient	Not publicly listed
Routine HRT bloodwork for every patient	Not publicly listed

Noom’s clinical leadership checks out as a serious program feature. The remaining question is whether its actual care model and narrow formulary fit your symptoms, state, and payment route.

Use Find My HRT Path to identify the provider model that fits those details →

What happens after you sign up for Noom HRT?

You complete an online medical intake, a licensed clinician reviews it, and medication is prescribed only if the clinician decides it is appropriate. Most medication-included Noom Med shipments are published as shipping within 3–7 business days, and ongoing questions go through the in-app “Your Doctor” chat, where Noom says replies usually arrive within 36 hours.

1. You complete the intake

Noom describes a brief or comprehensive health intake depending on the page. Expect questions about symptoms, menstrual and surgical history, medical conditions, medications, and goals. The exact eligibility rules and disqualifying conditions are not published as a complete list.

Do not edit yourself into eligibility. The questionnaire is part of the safety screen. A history of unexplained bleeding, clotting, certain cancers, liver disease, stroke, or other risk factors can materially change whether online prescribing is appropriate.

2. A clinician reviews the case

The clinician decides whether to prescribe and which route is appropriate. You do not select a medication from a storefront and automatically receive it.

You can—and should—state a preference:

“I prefer an FDA-approved estradiol product. Is the patch appropriate for me, and if not, why not?”

That is not self-prescribing. It is informed consent.

3. The prescription is filled and shipped

Noom says most medication-included Noom Med medications ship within 3–7 business days. Treat that as a general published target, not a guarantee for every HRT order. Pharmacy processing, clinician questions, stock, weather, and address problems can change the timeline.

Noom’s terms say most prescriptions may be sent to a pharmacy of the patient’s choice, while some compounded prescriptions can only be filled by a pharmacy on the platform. Because the HRT price is marketed as medication-inclusive, ask whether using an outside retail pharmacy is available for the patch and whether doing so changes the subscription price.

4. Ongoing questions go through the app

Noom’s support documentation says HRT Rx members can message the clinical team through “Your Doctor” and that replies usually arrive within 36 hours. Noom describes the channel more like email than instant chat.

That is a concrete, useful service level. It is also a limit. Thirty-six-hour messaging can work for routine questions, dose tolerance, and refill issues. It is not urgent care, and it is not a promise of a same-week video appointment.

5. The Noom program runs beside the prescription

The rest of the subscription is the Noom product: lessons, food logging, coaching, movement content, meal planning, menopause education, and community. That layer can be the reason to choose Noom—or the reason not to pay for it.

Does Noom HRT require blood tests or a video visit?

Noom does not publish routine hormone bloodwork or a mandatory video visit as universal requirements for Noom + HRT Rx. That does not prove a clinician will never request testing or synchronous evaluation; it means the public pathway begins with an online intake and leaves patient-specific requirements to clinical judgment.

Routine hormone panels are not always necessary to diagnose menopause in a woman of typical age with a characteristic symptom and menstrual history. Hormone levels fluctuate during perimenopause, and treatment is commonly guided by symptoms, history, contraindications, and response rather than a single estradiol or FSH result.

That is why “no universal hormone panel” is not automatically a safety failure.

The limitation appears when the case is not routine. Testing or in-person evaluation may be more important when symptoms begin unusually early, menstrual history is unclear, pregnancy is possible, thyroid or other conditions may mimic menopause, bleeding is unexplained, or the medical history changes the risk calculation.

Ask:

“Based on my age, bleeding pattern, medical history, and symptoms, do you recommend any examination, laboratory testing, imaging, or records before prescribing?”

The quality signal is not whether every woman gets the same panel. It is whether the clinician recognizes when your case should not follow the default path.

Does Noom prescribe vaginal estrogen or testosterone?

Noom’s published HRT program lists transdermal estrogen patches and body creams plus oral micronized progesterone. It does not publish a vaginal estrogen, oral estrogen, or testosterone option. That makes the program a better match for systemic symptoms than for women whose main problem is vaginal, vulvar, urinary, or libido-related.

The Noom formulary gap map

Primary problem	Does Noom’s public formulary contain a directly matched option?	What that means
Hot flashes and night sweats	Yes — systemic patch or body cream	Core fit, subject to clinical eligibility
Menopause-related sleep disruption driven by vasomotor symptoms	Yes — systemic treatment may be considered	Reasonable fit when symptoms are part of a systemic cluster
Bone-loss prevention when hormone therapy is otherwise appropriate	Yes — approved systemic estrogen products can have this indication	Requires individualized risk-benefit decision
Vaginal dryness or irritation as the main problem	No published local vaginal estrogen	A provider with local vaginal options may be a better first door
Painful sex related to genitourinary syndrome of menopause	No published local vaginal estrogen	Noom’s systemic menu may not be the most targeted route
Urinary symptoms or recurrent UTIs associated with GSM	No published local vaginal estrogen	Look for a provider that evaluates and treats GSM directly
You specifically want oral estrogen	No published oral estrogen	Noom is not a route-flexible fit
Low desire after other contributors are assessed	No published testosterone	Noom’s public formulary does not cover that route

Noom’s marketing page mentions vaginal dryness, painful intercourse, bladder infections, urinary incontinence, and sex-drive changes among menopause symptoms. That is not the same as publishing a medication specifically targeted to each symptom.

Systemic estrogen can improve some genitourinary symptoms for some women. But when vaginal or urinary symptoms are the main complaint, low-dose local vaginal treatment is often considered because it targets those tissues with lower systemic exposure. A broad symptom list on a landing page should not be read as a broad formulary.

Testosterone requires a separate level of clarity

Noom does not publish testosterone in this program. In the United States, testosterone is a Schedule III controlled substance and requires a prescription. No online provider should present it as an ordinary wellness add-on, imply guaranteed access, or minimize the controlled-substance and clinical-assessment requirements.

This is a scope limitation, not a scandal. Every program has a formulary. The point is to see the edge before paying.

Does Noom HRT take insurance, HSA, or FSA funds?

Noom’s direct retail HRT subscription is presented as cash-pay and does not bill your health insurance for the subscription. Noom says Noom + HRT Rx may generally qualify for HSA/FSA reimbursement, but it does not accept those cards directly for this program; you pay personally, request documentation, and submit the claim to your plan.

Insurance

Noom’s terms distinguish its direct retail programs from employer or health-plan arrangements. For the consumer HRT route reviewed here, Noom publishes the program as medication-inclusive and no-insurance-required. Do not assume the $89 or $149 subscription will be submitted to a commercial insurer, Medicare, or Medicaid.

That does not mean every Noom relationship everywhere is cash-pay. Noom also works with employers and health plans in other programs. It means this direct-to-consumer HRT price is not an insurance-billed clinic visit plus a pharmacy claim.

HSA and FSA reimbursement

Noom names Noom + HRT Rx on its HSA/FSA support page. Its stated process is:

1. Pay with a personal payment method.
2. Obtain the subscription receipt.
3. Request a Letter of Medical Necessity from the clinician.
4. Submit both to the HSA/FSA administrator.

Noom says most plans should cover eligible medical expenses but cannot guarantee reimbursement. Your plan administrator decides.

Refunds

Noom’s current refund page covers Noom Med and specifically states:

• refunds may be available before a prescription is written;
• medication-included Noom Med programs are not refundable once a prescription is written;
• renewal charges are not refundable.

That is a meaningful pre-pay boundary. The safest time to settle price, state, medication preference, and progesterone questions is before the clinician writes the prescription.

Cancellation

Noom says you can cancel through its app, web Subscription Portal, or the relevant app store if that is where you subscribed. Deleting the app does not cancel the subscription. Noom’s terms instruct members to cancel before 11:59 p.m. Eastern Time on the day before the next recurring billing date.

Cancellation stops future renewal; it does not automatically reverse a charge or a prescription already written. Access generally continues through the paid term.

What happens to an existing Noom Weight subscription?

Noom launched HRT as an upgrade. Its current Med-upgrade instructions say that when an existing Noom Weight or Premium member upgrades to Noom Med, the existing subscription ends immediately and the Med subscription begins.

That confirms the published upgrade flow is replacement, not two simultaneous Noom subscriptions. Still check the checkout summary if you enter through a different offer or app-store path, because the receipt—not an old launch announcement—controls what you are charged.

The ownership question

Noom acquired Tailor Made Compounding, a 503A pharmacy, on April 1, 2026. No public source we found identifies Tailor Made as the pharmacy filling Noom’s HRT cream. Do not infer that relationship from the acquisition alone.

Ask for the dispensing pharmacy name before or when the prescription is issued. If ownership matters to you, ask whether Noom or an affiliate owns that pharmacy.

If recurring cash cost is the dealbreaker, change the billing model rather than forcing the subscription. Midi Health is available nationwide and is in-network with most PPO plans, although coverage, copays, deductibles, and state-plan exclusions vary. (Affiliate link; verify your exact plan.)

Prefer a monthly menopause-care membership with video visits rather than a behavior app? See Sesame’s current menopause program and confirm the medication, laboratory, and pharmacy costs that apply to your plan. (Affiliate link.)

For the full policy breakdown, see Does Noom HRT take insurance?.

Is Noom HRT about menopause or weight loss?

It is a menopause prescription program sold inside a weight-management ecosystem. Noom’s landing page says women using Noom with HRT lost 3.3 times more weight than a comparison group, while Noom’s own educational content says HRT is not a weight-loss treatment. Both can be true only if the claimed advantage comes from the combined program or symptom relief—not from presenting HRT itself as a fat-loss drug.

What the 3.3× claim actually cites

Noom’s landing page includes a footnote describing a comparison involving 200 Noom Healthy Weight users with active menopause symptoms who used HRT and women with active menopause symptoms who received twice-monthly weight-loss education in an independent third-party study.

What the page does not provide is the full study report, named investigator, protocol, baseline table, statistical analysis, effect size in pounds or percentage, or a linked peer-reviewed publication. That means the claim should be treated as company-published study information with limited public methods, not dismissed as uncited and not repeated as independent clinical proof.

What Noom says elsewhere

Noom’s educational content separately states that hormone therapy is not a direct weight-loss treatment and is not FDA-approved for weight loss. It may help symptoms or body-composition factors that make behavior change harder, but it should not be prescribed as a substitute for weight treatment.

That is the right practical distinction:

• HRT can treat appropriate menopause symptoms.
• Better sleep, fewer hot flashes, and improved daily function may make movement, food planning, and recovery more possible.
• The Noom app can provide behavior structure.
• None of that turns an estrogen prescription into an approved weight-loss drug.

If weight loss is your only reason for seeking HRT, stop there. Noom’s own responsible language says that is the wrong way to frame the prescription.

Where the overlap is real

If night sweats wake you repeatedly, you are not starting the next day with the same capacity. If hot flashes derail training, or mood and concentration symptoms make planning harder, symptom relief can remove a barrier. A program that treats eligible symptoms and supplies habit support can be efficient for a woman who wants both.

The conversion question is not “Can hormones make me thin?” It is:

“Would treating my menopause symptoms and having one structured behavior program help me do the work I already know I need to do?”

For the right woman, yes. For the woman who only wants a prescription, it is an expensive way to get an app she may ignore.

What does the Noom app add to HRT care?

The app adds daily behavior support: food and activity tracking, psychology-based lessons, coaching, meal planning, resistance training, menopause content, and community. That is Noom’s clearest competitive advantage, but only for someone who will use it. The public data do not support pretending we can isolate an exact dollar value for the app layer.

A tempting comparison is to subtract changing retail coupon prices for estradiol and progesterone from Noom’s annual subscription and call the remainder the price of the app and care layer. That math would look precise while resting on unknowns:

• Noom does not publish the patch product or dose.
• Progesterone price inclusion is unresolved.
• Retail coupon prices change by pharmacy and date.
• The intro period is undefined.
• Taxes may apply.
• The subscription includes clinical access, fulfillment, and support—not just software.

The better decision test is behavioral:

Noom earns its price if:

• you want medication and behavior support in one place;
• you will log food or activity several times a week;
• coaching and structured lessons have helped you before;
• resistance training and meal planning are real needs, not decorative features;
• you would otherwise pay separately for menopause care and a behavior program.

Noom loses its price if:

• you only want the prescription;
• you have already abandoned Noom more than once;
• daily logging makes you feel watched rather than supported;
• you have insurance that can cover a specialist visit and approved medication;
• weight-centered care is the wrong emotional container for your menopause treatment.

If you have a history of disordered eating, compulsive tracking, or significant distress around weight, food logging and weigh-ins are not neutral features. Raise that before enrolling. The best hormone route can still sit inside the wrong care environment.

What do Noom HRT reviews say—and what do they not prove?

There is not yet a trustworthy public review pool specific to Noom + HRT Rx. Noom’s large general review footprint and the testimonials on its broad cost page mainly concern weight loss, coaching, or weight medication; they should not be presented as evidence about menopause prescribing, HRT follow-up, or the compounded cream.

Noom launched this program in February 2025. A platform-wide star rating combines years of experiences with a different product. It can tell you something about app usability, customer support, subscription expectations, and brand familiarity. It cannot answer:

• whether the HRT intake felt clinically thorough;
• whether progesterone was included in the published price;
• how quickly symptoms and side effects were handled;
• which pharmacy dispensed the cream;
• whether the 36-hour message target was met;
• how cancellation affected medication continuity.

The Noom cost page includes customer testimonials, but the visible examples are framed around pounds lost and general Noom or medication experiences. They are not labeled as Noom + HRT Rx patient reviews. This page will not move them across product lines to manufacture social proof.

A separate Stella-branded partnership experience should not be used as social proof for Noom + HRT Rx. That would create the exact evidence blur this review criticizes elsewhere.

Where HRT-specific social proof is missing, the honest substitute is document evidence: published prices, formulary statements, policy language, shipping targets, response targets, regulatory status, and the list of unresolved questions.

That is less comforting than a perfect five-star quote. It is more useful before a prescription.

And if you are here because your regular doctor brushed you off: you are not being dramatic. Being told to live with disruptive symptoms is a valid reason to seek another qualified clinician. The goal is not to find someone who will automatically say yes. It is to find someone who will take the question seriously and explain the answer.

Who is Noom HRT best for—and who should look elsewhere?

Noom fits best when systemic symptoms and behavior-change goals overlap, the patient is comfortable paying cash, and the app will be used. It fits poorly when local vaginal treatment, insurance billing, broad medication choice, scheduled video care, or non-weight-centered support is the priority.

If this is you	Noom fit	Best first move	Why
Hot flashes or night sweats are primary, and you want habit support too	Good potential fit	Ask whether the $149 FDA-approved patch route is appropriate	Systemic route plus Noom’s strongest differentiator
You want systemic HRT but strongly prefer FDA-approved finished drugs	Conditional fit	State that preference before the prescription is written	Noom publishes an approved patch route but also a compounded route
Vaginal dryness, painful sex, or urinary symptoms are primary	Poor fit	Choose a provider that publishes local vaginal options	Noom’s public formulary does not list vaginal estrogen
You have PPO insurance you want to use	Usually poor fit	Check an insurance-billed menopause clinic	Direct retail Noom HRT is cash-pay
You only want a prescription and pharmacy choice	Partial fit at best	Compare an unbundled visit model	Much of Noom’s value is the app and behavior program
You want a required live video visit	Unclear fit	Ask Noom or choose a provider that publishes video care	No universal video requirement is published
You want routine lab testing included	Unclear fit	Ask what your history requires	No universal HRTRx lab package is published
You have no uterus	Potential fit; confirm price	Ask whether the plan changes without progesterone	Noom says progesterone may not be prescribed
You have a history of disordered eating or tracking distress	Consider carefully	Discuss whether a weight-centered app is appropriate	Food and weight tracking are core product features
You have unexplained postmenopausal bleeding or a complex contraindication history	Do not start with a generic online funnel	Seek direct clinical evaluation	Examination, imaging, records, or testing may be needed first

If you are in a poor-fit row, do not force Noom to become the provider it is not. That is how people lose time: they complete an intake, reach the formulary edge, and end up searching again from the beginning.

Find My HRT Path maps your symptoms, route preference, coverage, and state to the right provider model →

Noom vs. Midi vs. Winona vs. Sesame: which model fits whom?

Noom sells a medication-included cash subscription plus a behavior-change platform. Midi is a specialist virtual clinic available in all 50 states and in-network with most PPO plans, with coverage varying by plan. Winona is cash-pay with a wider published product menu. Sesame publishes a $59-per-month menopause membership with video visits and ongoing messaging.

Feature	Noom + HRT Rx	Midi Health	Winona	Sesame menopause care
Core model	Medication-included cash subscription + behavior app	Insurance-billed or self-pay specialist visits	Cash-pay treatment subscriptions	Monthly care membership
Current public starting care price	$69 cream intro / $99 patch intro; terms undefined	$250 initial / $150 continued self-pay; insurance may reduce cost	Products from $27–$149 depending on item	From $59/month
Insurance	Direct retail HRT program is cash-pay	In-network with most PPO plans; verify exact coverage	Does not bill insurance directly	Cash-pay membership; verify reimbursement separately
FDA-approved patch	Yes, $149/month route	Can prescribe appropriate approved products through a pharmacy	Yes, from $149/month	Provider may prescribe approved options when appropriate; product cost varies
Compounded body cream	Yes, $89/month route	Not the defining published lane	Yes, from $89/month	Medication options depend on clinician; do not assume compounded or approved status without the prescription
Vaginal estrogen published	No	Yes, route options determined in care	Yes, from $89/month for compounded vaginal cream	Sesame publishes access to estradiol prescriptions and menopause treatment for vaginal symptoms
Video visits	Not published as universal	Yes	Intake and messaging model; verify live-visit access	Yes, as needed
Labs	No universal HRT lab package published	Clinician-directed	Not required to start according to Winona’s public model	Sesame publishes lab access in its menopause membership
Medication destination	Shipped in medication-included program; some compounded prescriptions restricted to platform pharmacies	Prescription generally sent to pharmacy	Winona fulfills and ships	Prescription may be sent to a pharmacy; confirm medication cost
Behavior-change app	Yes	No equivalent bundled Noom program	No equivalent bundled Noom program	No equivalent bundled Noom program
State availability	No public state list found	Available in all 50 states	Check current state availability	Depends on provider licensing and availability

Choose Noom when the bundle is the point

Noom wins for the woman who wants systemic treatment and the Noom behavior program in one subscription. No other provider in this table is selling that exact combination.

Choose an insurance-billed model when coverage is the point

Midi is available nationwide and says it is in-network with most PPO plans, but exact coverage, copays, deductibles, and exclusions vary. It does not participate in Medicaid or Medi-Cal. Do not replace Noom’s clear cash price with a vague promise that insurance will always be cheaper; check the plan.

Choose a wider cash-pay formulary when route choice is the point

Winona publishes body cream, patch, progesterone capsules, vaginal estrogen cream, and oral estrogen products. Its current headline cream and patch prices mirror Noom’s $89 compounded / $149 FDA-approved split. That wider menu can matter more than the app when the route is the deciding factor.

Choose Sesame when live video and a care membership are the point

Sesame publishes a menopause membership from $59 per month with video visits as needed, unlimited messaging, and access to prescriptions and labs. Medication costs and the exact formulation are separate decision points. Confirm whether the clinician is prescribing an FDA-approved or compounded product and what the pharmacy will charge.

Affiliate disclosure: The HRT Index may earn a commission from Midi or Sesame links. We receive no compensation from Noom links. The comparison above uses the same five-part order for every provider: clinical legitimacy, care quality, medication fit, price transparency, access.

What does Noom’s safety page get right—and where does it overreach?

Noom correctly states that compounded drugs are not FDA-reviewed and correctly highlights that modern hormone-therapy decisions depend on age, timing, route, formulation, and individual risk. Its page becomes less reliable when it frames “bioidentical” hormones as lower risk, calls estriol gentler, or presents broad benefit claims without keeping product-specific labeling and remaining risks equally visible.

What changed at the FDA in 2026

On February 12, 2026, the FDA approved labeling changes for six specific menopausal hormone therapy products. The changes removed boxed-warning statements related to cardiovascular disease, breast cancer, and probable dementia from those products.

That is a real regulatory change. It is not a blanket deletion of every warning from every estrogen or estrogen–progestogen product. The FDA separately said it did not request removal of the boxed warning about endometrial cancer from systemic estrogen-alone products.

The final prescription label still matters. Product, route, dose, duration, age, time since menopause, uterus status, and health history change the risk-benefit conversation.

What Noom gets right

Noom is right that the public conversation after the 2002 Women’s Health Initiative became overly broad and frightened many symptomatic women away from treatment without an individualized discussion. It is also right that transdermal and oral routes are not identical and that timing matters.

Noom deserves credit for publishing its compounded-drug disclaimer and naming its medication categories. That is more useful than calling everything “bioidentical HRT” and leaving the regulatory status invisible.

Where the language needs a counterweight

Noom’s page says bioidentical hormones are associated with less risk and fewer side effects and calls estriol a gentler estrogen included to reduce side effects. Those statements blur distinct questions:

• molecular structure;
• route of administration;
• dose;
• approved versus compounded status;
• evidence for the finished product;
• individual risk.

The FDA says it has no evidence that compounded bioidentical hormones are safer or more effective than FDA-approved hormone therapy and no evidence that estriol is a safer estrogen. The Menopause Society and Endocrine Society also make clear that FDA-approved bioidentical products exist.

The safe sentence is not “bioidentical is better.” It is:

The clinician should choose an evidence-supported product, route, and dose that fits the patient’s symptoms, uterus status, preferences, and risk history.

The label asymmetry remains

An FDA-approved patch comes with standardized prescribing information describing indications, contraindications, warnings, adverse reactions, dosing, and manufacturing controls. A compounded cream does not have an FDA-approved label for that finished formulation.

Noom’s testing and COA statements may add quality-control information. They do not replace the missing FDA review or standardized approved labeling.

What side effects require more than an app message?

Breast tenderness, bloating, headache, skin irritation, nausea, and bleeding changes can occur after starting hormone therapy, but new bleeding after menopause needs clinical evaluation rather than automatic reassurance. Chest pain, sudden shortness of breath, one-sided leg swelling, sudden neurologic symptoms, or major vision changes require urgent or emergency care.

Noom’s safety page says temporary vaginal bleeding or spotting can occur. That can be true during hormone-therapy initiation, especially depending on regimen and menopause stage. It should not become permission to self-triage every bleeding episode for months.

Please read this part properly

Bleeding after menopause is not something to manage only inside a chat queue.

ACOG states that postmenopausal bleeding warrants prompt evaluation because clinicians must rule out endometrial cancer and other causes. The workup may include transvaginal ultrasound, endometrial sampling, examination, or other testing depending on the case.

If bleeding begins after menopause, becomes heavy, persists, or changes unexpectedly while you use hormone therapy, contact a clinician directly. When the symptom is severe or accompanied by dizziness, weakness, or pain, seek urgent care.

The same boundary applies to symptoms that may signal a blood clot, stroke, or other serious reaction. A 36-hour messaging target is not an emergency pathway.

If you have a uterus, endometrial protection is not optional

Systemic estrogen can stimulate the uterine lining. A woman with an intact uterus usually needs an appropriate progestogen strategy unless a clinician has a different evidence-based plan.

That makes the progesterone question the most important unresolved commercial fact on this page. It changes both safety and cost.

Do not change, stop, or add hormones based on this review. Get the exact regimen in writing and ask how the clinician plans to protect the endometrium.

What should you ask Noom before you pay?

Eight questions resolve nearly every material gap left by Noom’s public pages. Ask them before the prescription is written, because the refund boundary changes after that point. Save the checkout terms and responses so the price, product, pharmacy, and cancellation expectations are documented.

Copy and paste this list:

1. What period does the introductory payment cover, when is the next charge, and is the recurring price billed monthly or in a prepaid term?
2. If I have a uterus and progesterone is prescribed, is it included in the quoted cream or patch price?
3. What exact medication, manufacturer or compounding pharmacy, strength, directions, and quantity would I receive?
4. Is Noom + HRT Rx currently available in my state, and is the reviewing clinician licensed there?
5. If I prefer the FDA-approved estradiol patch, is that clinically appropriate for me? If not, what specific issue makes the compounded cream a better fit?
6. Can I receive the Certificate of Analysis for a compounded prescription, and what does it test?
7. Based on my history, do I need records, an examination, bloodwork, imaging, or a live visit before starting?
8. What happens to refills, access, and any existing Noom subscription if I cancel or switch pharmacies?

Add one more if vaginal or urinary symptoms brought you here:

“Does your current formulary include local vaginal estrogen or another treatment aimed specifically at genitourinary syndrome of menopause?”

Noom’s public answer appears to be no. Let the clinician confirm before you spend twenty minutes in the funnel.

If the answers line up—systemic symptoms, cash-pay, app support, and an FDA-approved patch you are comfortable with—Noom has a coherent reason to win. Check current Noom eligibility and pricing → (editorial link; no compensation to The HRT Index).

If one of those answers breaks the fit, do not force it. Use Find My HRT Path to compare the provider models that match your medication route, state, and coverage →

How did The HRT Index review Noom HRT?

This page was produced under The HRT Index Verification Standard: read every published price, separate FDA-approved from compounded, verify state availability and insurance, and re-check on a fixed schedule—top providers monthly, full roster quarterly. It is editorial research and has not been reviewed by a clinician.

We evaluate providers on five pillars, always in this order: clinical legitimacy, care quality, medication fit, price transparency, access. We do not publish invented numeric provider scores.

What we actually verified

Item	Primary source	Checked
Launch date and original $69/$89 and $99/$149 pricing	Noom HRT launch announcement	Aug. 17, 2026
Current prices, inclusions, and HSA/FSA summary	Noom 2026 cost page	Aug. 17, 2026
Patch, progesterone, compounded cream, estriol, testing, COA, and clinician biographies	Noom HRT Safety & Transparency	Aug. 17, 2026
Public symptom marketing and 3.3× footnote	Noom menopause landing page	Aug. 17, 2026
Noom’s statement that HRT does not itself cause weight loss	Noom menopause weight article	Aug. 17, 2026
36-hour message target	Noom clinician-contact support page	Aug. 17, 2026
General medication-included shipping target	Noom medication shipping	Aug. 17, 2026
Refund boundary	Noom refund policy	Aug. 17, 2026
Cancellation routes	Noom cancellation instructions	Aug. 17, 2026
Platform, pharmacy, cash-pay, renewal, tax, and Medicare/Medicaid terms	Noom Terms and Conditions	Aug. 17, 2026
Existing-subscription upgrade flow	Noom Med upgrade instructions	Aug. 17, 2026
HSA/FSA reimbursement steps	Noom HSA/FSA support	Aug. 17, 2026
Tailor Made acquisition	Noom pharmacy acquisition announcement	Aug. 17, 2026
Compounded and estriol regulatory statements	FDA menopause questions	Aug. 17, 2026
2026 product-specific label changes	FDA labeling-change announcement and FDA safety-information request	Aug. 17, 2026
FDA-commissioned review of compounded bioidentical HRT	FDA summary of the NASEM report	Aug. 17, 2026
Bioidentical and compounded distinction	The Menopause Society hormone-therapy guide	Aug. 17, 2026
Compounded prescribing position	ACOG Clinical Consensus	Aug. 17, 2026
Compounded evidence and oversight position	Endocrine Society position statement	Aug. 17, 2026
Compounded cream exposure study	Newman et al., 2023, PubMed	Aug. 17, 2026
Testosterone scheduling	DEA drug scheduling	Aug. 17, 2026
Current Winona comparison prices	Winona products	Aug. 17, 2026
Current Midi availability and insurance language	Midi pricing and insurance	Aug. 17, 2026
Current Sesame menopause membership	Sesame menopause treatment	Aug. 17, 2026

What we could not verify

We could not verify a complete HRTRx state list, a patient-specific compounding pharmacy, the cream concentration, the patch product and strength, progesterone’s headline-price inclusion, the intro-price duration, a universal video requirement, a universal bloodwork requirement, or a fixed scheduled follow-up cadence.

Those gaps remain labeled. We did not fill them with affiliate math or assumptions.

About Noom’s billing history

In 2022, a federal court approved a settlement in the consolidated Noom auto-renewal litigation, commonly captioned Nichols et al. v. Noom, Inc. The settlement created a $56 million cash fund plus subscription credits valued at $6 million. The allegations concerned trial conversion, recurring charges, and cancellation—not HRT clinical care, which did not exist at the time.

Three things belong together:

1. The case settled; the allegations were not adjudicated findings of liability.
2. The conduct predated Noom + HRT Rx by years and does not prove anything about menopause prescribing quality.
3. It makes current billing clarity relevant, which is why this review verified the present refund and cancellation rules rather than using the old case as a character attack.

The current practical rule is simple: read the term, save the receipt, know the next charge date, and cancel through the account route rather than deleting the app.

Noom HRT review: frequently asked questions

Is Noom HRT legit?

Yes. Noom publicly operates a real menopause program, publishes clinical leadership and prices, and connects patients to licensed clinicians. The open questions involve formulary breadth, state availability, pharmacy identity, follow-up details, and price transparency—not whether the program exists.

How much is Noom HRT per month?

Noom publishes a compounded cream route at $69 to start and then $89 per month, and an FDA-approved patch route at $99 to start and then $149 per month. Noom does not define the introductory period in the HRT price block, so confirm the next charge and billing term.

Is Noom HRT FDA approved?

Partly. Noom describes its estradiol patch and micronized progesterone pill as FDA-approved. Its estradiol–estriol body cream is compounded and not FDA-approved.

What is the real difference between Noom’s $89 and $149 routes?

The estrogen product and regulatory category. The $89 recurring route uses a compounded estradiol–estriol cream; the $149 route uses an FDA-approved estradiol patch. Dose, pharmacy, intro term, and progesterone inclusion also need confirmation.

Does the Noom HRT price include medication?

Noom says the HRT price covers the prescription, clinical guidance, and wellness tools. It does not separately state whether a progesterone prescription changes the headline price for a patient with a uterus.

Does Noom prescribe progesterone?

Yes. Noom lists an FDA-approved oral micronized progesterone pill and says a patient without a uterus may not receive it. Ask whether it is included in your quoted price and what schedule is prescribed.

What is in Noom’s compounded cream?

Noom says the bi-est body cream contains estradiol and estriol. It does not publish the concentration, estradiol-to-estriol ratio, dose, or dispensing pharmacy on the public price page.

Is estriol FDA approved?

No estriol-containing drug is FDA-approved in the United States. Estriol can appear in a lawfully compounded prescription, but the finished compounded medication is not FDA-approved.

Can I ask for the patch instead of the cream?

Yes, you can state an informed preference. The clinician makes the prescribing decision. Ask whether the FDA-approved patch is appropriate for you and what specific clinical reason would favor the compounded route if it is not.

Does Noom offer vaginal estrogen?

No vaginal estrogen appears in Noom’s published HRT formulary. If vaginal dryness, painful sex, or urinary symptoms are your main concern, consider a provider that publishes local vaginal treatment options.

Does Noom prescribe oral estrogen?

Noom states that it prescribes transdermal estrogen patches and creams in this program. No oral estrogen product appears in the public HRTRx formulary.

Does Noom prescribe testosterone for women?

No testosterone product appears in Noom’s published HRT formulary. Testosterone is a Schedule III controlled substance in the United States and requires a prescription and appropriate clinical assessment.

Does Noom HRT require blood tests?

No universal routine blood-test requirement is published for Noom + HRT Rx. A clinician may still decide testing, records, imaging, or in-person evaluation is needed based on age, bleeding, symptoms, or medical history.

Does Noom require a video visit?

Noom does not publish a mandatory video visit for every HRTRx patient. Its public process begins with an online intake and clinician review. Confirm the available visit format if live conversation is important to you.

How fast does Noom HRT ship?

Noom says most medication-included Noom Med medications ship within 3–7 business days. That is a general target, not a guarantee for every HRT order.

How fast does a Noom clinician respond?

Noom says messages sent through the in-app “Your Doctor” channel usually receive a response within 36 hours. It describes the channel more like email than instant messaging.

Does Noom HRT take insurance?

The direct retail program reviewed here is cash-pay and medication-inclusive. Do not expect Noom to submit the $89 or $149 subscription to commercial insurance, Medicare, or Medicaid.

Can I use HSA or FSA funds?

Noom says the program may generally qualify for HSA/FSA reimbursement, but it does not accept those cards directly for this route. Pay personally, obtain a receipt and Letter of Medical Necessity, and submit them to your plan. Reimbursement is not guaranteed.

What is Noom’s HRT refund policy?

Noom’s current medication-included Noom Med policy says refunds may be available before a prescription is written. No refund is available after a prescription is written, and renewal charges are nonrefundable.

How do I cancel Noom HRT?

Cancel through the Noom app, web Subscription Portal, or the app store used to subscribe. Deleting the app does not cancel. Noom’s terms say to cancel before 11:59 p.m. Eastern Time on the day before the next billing date.

What happens to my Noom Weight subscription if I upgrade?

Noom’s published Med upgrade flow says the existing Noom Weight or Premium subscription ends immediately when the Med upgrade begins. Confirm the final checkout summary if you are using a different offer or app-store purchase route.

What states is Noom HRT available in?

No public state-by-state HRTRx list was found as of August 17, 2026. Check eligibility for your state before paying.

Will Noom HRT make me lose weight?

HRT is not an FDA-approved weight-loss treatment. Noom publishes a 3.3× claim based on a described 200-user comparison, but does not link a full report or peer-reviewed publication. Buy HRT for an appropriate menopause indication, not as a fat-loss drug.

Is Noom better than Midi?

Noom is the stronger fit when the behavior-change app and medication bundle are the point. Midi is usually the stronger model when you want specialist virtual care billed to a compatible PPO plan and prescriptions handled through a pharmacy. Verify exact coverage.

Is Noom better than Winona?

Noom offers the stronger behavior-platform bundle. Winona publishes a wider treatment menu, including vaginal and oral options. Both currently publish $89 compounded cream and $149 FDA-approved patch headline prices, so compare route, progesterone, support, and total cost—not just the number.

Who should not start with a generic online HRT funnel?

Someone with unexplained postmenopausal bleeding, symptoms suggesting another condition, a complex cancer or clotting history, significant liver disease, prior serious cardiovascular events, or any situation requiring examination, imaging, or urgent assessment should begin with direct clinical evaluation. Online care may still become part of the plan later.

Bottom line: should you try Noom HRT?

Choose Noom when you want systemic menopause treatment and Noom’s behavior-change support in one cash-pay subscription, your main symptoms fit its published patch-or-body-cream formulary, and you will actually use the app. If FDA approval matters, state your preference for the $149 patch route before the prescription is written.

Choose another model when vaginal or urinary symptoms are primary, you want to use insurance, you want oral or local treatment choices, you need scheduled video care, or a weight-centered app is the wrong setting for your menopause care.

Before paying, settle four facts in writing:

1. the intro period and next charge;
2. the exact medication and strength;
3. whether progesterone is included;
4. the state, pharmacy, and cancellation path.

The deepest finding on this page is not that compounded medication is always wrong. It is that the cheaper Noom route changes regulatory category, and the price block does not tell you that. Once you see the distinction, you can ask a better question: not “Which one costs less?” but “Which formulation does my situation justify, and what am I giving up to get the lower price?”

If Noom’s answer fits—systemic symptoms, cash-pay, behavior support, and the medication route you want—see its current program and check eligibility (editorial link; The HRT Index receives no compensation).

Still not sure which HRT program is right for you? Take our free 60-second matching quiz.

→ Find My HRT Path

Get a personalized starting-point plan based on symptoms, medication route, state, and coverage—including a flag when online care is not the right first step.

---

The HRT Index publishes educational research, not medical advice. Talk with a licensed clinician before starting, stopping, or changing treatment. Seek urgent care for emergency symptoms.

Last verified: August 17, 2026 · Next scheduled re-verification: September 2026